诺和、礼来开始直接向雇主销售减肥药物
Novo, Lilly begin to sell obesity medications directly to employers
生物技术与制药领域的最新动态
Novo, Lilly begin to sell obesity medications directly to employers
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Lilly becomes first $1 trillion pharma company
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
Hikari Tsushin Inc. Raises Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
What to Expect from Agilent Technologies's Earnings - Benzinga
Agilent Technologies, Inc. (NYSE:A) to Issue Dividend Increase - $0.26 Per Share - MarketBeat
Vanguard Group Inc. Buys 589,219 Shares of Agilent Technologies, Inc. $A - MarketBeat
Primecap Management Co. CA Has $180.69 Million Stake in Agilent Technologies, Inc. $A - MarketBeat
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
Waters Corporation Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb's next move
FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M
Agilent Technologies, Inc. $A Shares Purchased by Nomura Asset Management Co. Ltd. - MarketBeat
GSK, Anaptysbio sue each other over Jemperli revenue
Gene Therapy Cell Culture Media Market By Top Companies-Lonza - openPR.com
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know - Yahoo Finance
Pharma faces a critical ‘turning point’ in 2026, years in the making
A brain biotech’s top drug fails against MS